Aun Consulting
2459
DMS
9782
Wellco Holdings
7831
Metaplanet
3350
Perseus Proteomics
4882
JP Stock MarketDetailed Quotes
4553 TOWA Pharmaceutical
- 2802
- +24+0.86%
20min DelayMarket Closed Mar 21 15:30 JST
144.35BMarket Cap8.53P/E (Static)
2816High2780Low106.00KVolume2780Open2778Pre Close296.86MTurnover339552wk High0.46%Turnover Ratio51.52MShares248852wk Low391.66EPS TTM64.69BFloat Cap3560Historical High8.53P/E (Static)23.09MShs Float623Historical Low328.59EPS LYR1.30%Amplitude60.00Dividend TTM0.82P/B100Lot Size2.14%Div YieldTTM
TOWA Pharmaceutical News
TOWA Pharmaceutical: Notice of Partial Revision of the Basic Policy for the Development of an Internal Control System
TOWA Pharmaceutical: Notice regarding partial revisions to the “Basic Policy on the Development of Internal Control Systems”
TOWA Pharmaceutical: Notice of Revision of Dividend Forecasts for the Fiscal Year Ending March 31, 2025 (69th Fiscal Year)
TOWA Pharmaceutical: Supplementary material for the financial results for the third quarter of the year ending March 31, 2025
TOWA Pharmaceutical: Consolidated Financial Results for the Nine Months Ended December 31, 2024 (Based on Japanese GAAP)
TOWA Pharmaceutical: TOWA PHARMACEUTICAL INTEGRATED REPORT 2024
TOWA Pharmaceutical: Towa Pharmaceutical Integrated Report 2024
TOWA Pharmaceutical: Supplementary material for the financial results for the second quarter (interim period) of the year ending March 31, 2025
TOWA Pharmaceutical: Consolidated Financial Results for the Six Months Ended September 30, 2024 (Based on Japanese GAAP)
TOWA Pharmaceutical: Notice of Revisions of Financial Forecasts
TOWA Pharmaceutical: Notice of Settlement of Lawsuit
TOWA Pharmaceutical: Notice of litigation resolution through settlement
TOWA Pharmaceutical: Announcements of individual stocks regarding revised financial forecasts.
TOWA Pharmaceutical: Supplementary materials for the first quarter financial statements of the year ending on March 31st, 2025.
TOWA Pharmaceutical: Consolidated financial results for the three-month period ending June 30, 2024 (based on Japanese accounting standards).
TOWA Pharmaceutical: Announcements of individual stocks: Notification of completion of disposal of treasury stock as stock compensation with transfer restrictions.
TOWA Pharmaceutical: Matters concerning the controlling shareholder.
TOWA Pharmaceutical: Notice of parent company's financial statements etc.
TOWA Pharmaceutical: Notification of disposal of own shares as transfer-restricted stock compensation.
TOWA Pharmaceutical: Announcements of individual stocks related to changes in company executives.